Deutsche Bank’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,122
Closed -$44.5K 3675
2025
Q1
$44.5K Hold
4,122
﹤0.01% 3396
2024
Q4
$52.8K Hold
4,122
﹤0.01% 3406
2024
Q3
$114K Buy
4,122
+1,206
+41% +$35.4K ﹤0.01% 3175
2024
Q2
$84.6K Sell
2,916
-710
-20% -$33.8K ﹤0.01% 3170
2024
Q1
$162K Buy
3,626
+126
+4% +$5.39K ﹤0.01% 2946
2023
Q4
$136K Sell
3,500
-116
-3% -$4.18K ﹤0.01% 3080
2023
Q3
$106K Buy
3,616
+605
+20% +$28.7K ﹤0.01% 3133
2023
Q2
$192K Sell
3,011
-2,287
-43% -$127K ﹤0.01% 2901
2023
Q1
$250K Buy
5,298
+1,552
+41% +$83K ﹤0.01% 2901
2022
Q4
$260K Buy
3,746
+57
+2% +$5.66K ﹤0.01% 2812
2022
Q3
$541K Sell
3,689
-401
-10% -$54.3K ﹤0.01% 2325
2022
Q2
$533K Buy
4,090
+45
+1% +$4.6K ﹤0.01% 2553
2022
Q1
$409K Buy
4,045
+3,328
+464% +$403K ﹤0.01% 2869
2021
Q4
$111K Buy
717
+37
+5% +$8.25K ﹤0.01% 3662
2021
Q3
$201K Buy
+680
New +$204K ﹤0.01% 3567

Other funds holding LYEL